MK

Muhminath Kizhakeparambil

Active Director Director/Designated Partner DIN 11881594
DIN 11881594 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Muhminath Kizhakeparambil

Muhminath Kizhakeparambil is a Director/Designated Partner at Fromex Health Tech Private Limited (since 2026).

DIN 11881594
Primary Designation Director/Designated Partner
First Appointment 13 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fromex Health Tech Private Limited U58201KL2026PTC105499
Director/Designated Partner13 Aug 20262026Active

Board colleagues of Muhminath Kizhakeparambil

NameDINCompanyDesignation
Abdul Shukur Konnadan11881593Fromex Health Tech Private LimitedDirector/Designated Partner

Directorship timeline

Open interactive timeline →
Fromex Health Tech Private Limited
Premium access

Shareholding and investment profile for Muhminath Kizhakeparambil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muhminath Kizhakeparambil

Muhminath Kizhakeparambil currently holds 1 directorship: Fromex Health Tech Private Limited (Director/Designated Partner, since 13 Aug 2026).

Muhminath Kizhakeparambil was first appointed on 13 Aug 2026 as Director/Designated Partner at Fromex Health Tech Private Limited.

The current boards of Muhminath Kizhakeparambil's companies include Abdul Shukur Konnadan (Fromex Health Tech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available